ONCIMMUNE LEADING EARLY CANCER DETECTION
 
ONCIMMUNE LEADING EARLY CANCER DETECTION

  • ONCIMMUNE is a leading early cancer testing business.

    Our proprietary technology can be used for most solid tumor types

    Read More...


  • Our simple blood test for lung cancer

    can be used in conjunction with CT and other imaging to assess the risk of lung cancer

    Read More


  • EarlyCDT®-Lung significantly aids the malignancy risk assessment of lung nodules.

    Our lung cancer test has high specificity and PPV and so can be used to rule-in for lung cancer.

    Read More


  • EarlyCDT®-Lung test is available now.

    It is reimbursable and can be billed to most major payors in the USA

    Read More...


  • EarlyCDT®-Liver will be launched in early 2018

    Read More.

PLEASE READ THE FOLLOWING STATEMENT CAREFULLY

Electronic versions of the materials you are seeking to access are being made available on this website by Oncimmune Holdings plc (the “Company”).

These materials are not directed to nor are they intended for access by persons located or resident in the United States, Australia, Canada, South Africa, Japan or any other jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction.

None of the securities of Company discussed or referred to in the materials you are seeking to access have been registered under the US Securities Act or 1933, as amended (the “Securities Act”) and may not be offered, sold, pledged or otherwise transferred except (1) in an offshore transaction meeting the requirements of Rule 903 or Rule 904 of Regulation S under the Securities Act, (2) pursuant to an effective registration statement under the Securities Act, or (3) pursuant to an available exemption from the registration requirements of the Securities Act, in each case in accordance with all applicable securities laws.

By clicking the “SUBMIT” button below you confirm that you (1) have read and understood the information set out above, (2) agree to be bound by its terms, (3) are not located in the United States and do not have a registered address in, and are not resident or located in, Australia, Canada, South Africa or Japan and (4) are permitted under applicable law and regulation to proceed to the following parts of this website.

Please click on the button below to confirm that you have read, understood and agree with the disclaimer above.

Yes, I accept No, I don't accept